Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors
Purpose Dogs have been proposed as spontaneous animal models of human breast cancer, based on clinicopathologic similarities between canine and human mammary carcinomas. We hypothesized that a better knowledge of the natural history and prognostic factors of canine invasive mammary carcinomas would...
Gespeichert in:
Veröffentlicht in: | Breast cancer research and treatment 2018-02, Vol.167 (3), p.635-648 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 648 |
---|---|
container_issue | 3 |
container_start_page | 635 |
container_title | Breast cancer research and treatment |
container_volume | 167 |
creator | Nguyen, Frédérique Peña, Laura Ibisch, Catherine Loussouarn, Delphine Gama, Adelina Rieder, Natascha Belousov, Anton Campone, Mario Abadie, Jérôme |
description | Purpose
Dogs have been proposed as spontaneous animal models of human breast cancer, based on clinicopathologic similarities between canine and human mammary carcinomas. We hypothesized that a better knowledge of the natural history and prognostic factors of canine invasive mammary carcinomas would favor the design of preclinical trials using dogs as models of breast cancer.
Methods
The 2-year outcome of 350 female dogs with spontaneous invasive mammary carcinoma was studied. The investigated prognostic factors included age at diagnosis, pathologic tumor size, pathologic nodal stage, lymphovascular invasion, histological grade, and expression of Estrogen Receptor alpha (ERα), Progesterone Receptor, Ki-67, Human Epidermal Growth Factor Receptor 2, basal cytokeratins 5/6, and Epidermal Growth Factor Receptor. Multivariate survival analyses were performed using the Cox proportional hazards model.
Results
The overall survival after mastectomy was 11 months. Within 1 year post mastectomy, 41.5% of dogs (145/350) died from their mammary carcinoma. By multivariate analysis, the significant prognostic factors for overall survival included a pathologic tumor size larger than 20 mm [HR 1.47 (95% confidence interval 1.15–1.89)], a positive nodal stage [pN+, HR 1.89 (1.43–2.48)], a histological grade III [HR 1.32 (1.02–1.69)], ERα negativity [HR 1.39 (1.01–1.89)], a high Ki-67 proliferation index [HR 1.32 (1.04–1.67)], and EGFR absence [HR 1.33 (1.04–1.69)].
Conclusion
The short natural history of spontaneous canine invasive mammary carcinomas and high rate of cancer-related death allow for rapid termination of preclinical investigations. The prognostic factors of invasive mammary carcinomas are remarkably similar in dogs and humans, highlighting the similarities in cancer biology between both species. |
doi_str_mv | 10.1007/s10549-017-4548-2 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5807494</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A527129706</galeid><sourcerecordid>A527129706</sourcerecordid><originalsourceid>FETCH-LOGICAL-c671t-296ff29315546b04800303b066b19d06e2d317fc069c5d52654609a596d3c7093</originalsourceid><addsrcrecordid>eNp1klGL1DAUhYso7rr6A3yRgCA-2PEmbZLJPgjDoK4woA_6HDJpOs3SJmPSDvjvvWXWdWbRthBIvnNy7-ktipcUFhRAvs8UeK1KoLKseb0s2aPiknJZlZJR-bi4BCpkKZYgLopnOd8CgJKgnhYXTMFSsIpeFnltgg-O-HAw2R8cGcwwmPSLWJOsD3EwmeA3xMb1mcSWdNNgAtkmZ_KIULAuLcg3k0ZCr0kw45RMTzqfx4gmJjRkn-IuxDx6S1pjcTs_L560ps_uxd16Vfz49PH7-qbcfP38Zb3alFZIOpZMibZlqqKc12IL9RKggmoLQmypakA41lRUthaEsrzhTCAGynAlmspin9VV8eHou5-2g2usCyMWp_fJzx3qaLw-Pwm-07t40HwJslY1Grw7GnQPZDerjfYhuzRozJgprO1AEX97d1-KPyeXRz34bF3fm-DilDVVfMkrVYkZff0AvY1TCpgGUvjQuf6_1M70Di9sI5ZpZ1O94kxShr9TILX4B4Vv4wZvY3Ctx_0zwZsTQedMP3Y59tPoY8jnID2CNsWck2vvQ6Cg5wnUxwnEEKSeJ1Az1Lw6Df1e8WfkEGBHIONR2Ll00vp_XX8DZv7jMg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1999917093</pqid></control><display><type>article</type><title>Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Nguyen, Frédérique ; Peña, Laura ; Ibisch, Catherine ; Loussouarn, Delphine ; Gama, Adelina ; Rieder, Natascha ; Belousov, Anton ; Campone, Mario ; Abadie, Jérôme</creator><creatorcontrib>Nguyen, Frédérique ; Peña, Laura ; Ibisch, Catherine ; Loussouarn, Delphine ; Gama, Adelina ; Rieder, Natascha ; Belousov, Anton ; Campone, Mario ; Abadie, Jérôme</creatorcontrib><description>Purpose
Dogs have been proposed as spontaneous animal models of human breast cancer, based on clinicopathologic similarities between canine and human mammary carcinomas. We hypothesized that a better knowledge of the natural history and prognostic factors of canine invasive mammary carcinomas would favor the design of preclinical trials using dogs as models of breast cancer.
Methods
The 2-year outcome of 350 female dogs with spontaneous invasive mammary carcinoma was studied. The investigated prognostic factors included age at diagnosis, pathologic tumor size, pathologic nodal stage, lymphovascular invasion, histological grade, and expression of Estrogen Receptor alpha (ERα), Progesterone Receptor, Ki-67, Human Epidermal Growth Factor Receptor 2, basal cytokeratins 5/6, and Epidermal Growth Factor Receptor. Multivariate survival analyses were performed using the Cox proportional hazards model.
Results
The overall survival after mastectomy was 11 months. Within 1 year post mastectomy, 41.5% of dogs (145/350) died from their mammary carcinoma. By multivariate analysis, the significant prognostic factors for overall survival included a pathologic tumor size larger than 20 mm [HR 1.47 (95% confidence interval 1.15–1.89)], a positive nodal stage [pN+, HR 1.89 (1.43–2.48)], a histological grade III [HR 1.32 (1.02–1.69)], ERα negativity [HR 1.39 (1.01–1.89)], a high Ki-67 proliferation index [HR 1.32 (1.04–1.67)], and EGFR absence [HR 1.33 (1.04–1.69)].
Conclusion
The short natural history of spontaneous canine invasive mammary carcinomas and high rate of cancer-related death allow for rapid termination of preclinical investigations. The prognostic factors of invasive mammary carcinomas are remarkably similar in dogs and humans, highlighting the similarities in cancer biology between both species.</description><identifier>ISSN: 0167-6806</identifier><identifier>EISSN: 1573-7217</identifier><identifier>DOI: 10.1007/s10549-017-4548-2</identifier><identifier>PMID: 29086231</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Animal models ; Animals ; Breast cancer ; Breast Neoplasms - pathology ; Breast Neoplasms - surgery ; Cancer ; Cancer research ; Clinical trials ; Disease Models, Animal ; Dogs ; Epidermal growth factor ; Epidermal growth factor receptors ; Epidermal growth factors ; Estrogens ; Female ; Humans ; Invasiveness ; Life Sciences ; Mammary gland ; Mammary Neoplasms, Animal - genetics ; Mammary Neoplasms, Animal - pathology ; Mammary Neoplasms, Animal - surgery ; Mastectomy ; Medical prognosis ; Medicine ; Medicine & Public Health ; Multivariate Analysis ; Neoplasm Invasiveness - genetics ; Neoplasm Invasiveness - pathology ; Oncology ; Preclinical Study ; Progesterone ; Prognosis ; Receptor, ErbB-2 - genetics ; Receptors, Estrogen - genetics ; Receptors, Progesterone - genetics ; Survival</subject><ispartof>Breast cancer research and treatment, 2018-02, Vol.167 (3), p.635-648</ispartof><rights>The Author(s) 2017</rights><rights>COPYRIGHT 2018 Springer</rights><rights>Breast Cancer Research and Treatment is a copyright of Springer, (2017). All Rights Reserved.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c671t-296ff29315546b04800303b066b19d06e2d317fc069c5d52654609a596d3c7093</citedby><cites>FETCH-LOGICAL-c671t-296ff29315546b04800303b066b19d06e2d317fc069c5d52654609a596d3c7093</cites><orcidid>0000-0001-7203-2982 ; 0000-0002-3538-0782 ; 0000-0002-5196-5908 ; 0000-0002-7750-0519</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10549-017-4548-2$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10549-017-4548-2$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29086231$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://inserm.hal.science/inserm-01629480$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Nguyen, Frédérique</creatorcontrib><creatorcontrib>Peña, Laura</creatorcontrib><creatorcontrib>Ibisch, Catherine</creatorcontrib><creatorcontrib>Loussouarn, Delphine</creatorcontrib><creatorcontrib>Gama, Adelina</creatorcontrib><creatorcontrib>Rieder, Natascha</creatorcontrib><creatorcontrib>Belousov, Anton</creatorcontrib><creatorcontrib>Campone, Mario</creatorcontrib><creatorcontrib>Abadie, Jérôme</creatorcontrib><title>Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors</title><title>Breast cancer research and treatment</title><addtitle>Breast Cancer Res Treat</addtitle><addtitle>Breast Cancer Res Treat</addtitle><description>Purpose
Dogs have been proposed as spontaneous animal models of human breast cancer, based on clinicopathologic similarities between canine and human mammary carcinomas. We hypothesized that a better knowledge of the natural history and prognostic factors of canine invasive mammary carcinomas would favor the design of preclinical trials using dogs as models of breast cancer.
Methods
The 2-year outcome of 350 female dogs with spontaneous invasive mammary carcinoma was studied. The investigated prognostic factors included age at diagnosis, pathologic tumor size, pathologic nodal stage, lymphovascular invasion, histological grade, and expression of Estrogen Receptor alpha (ERα), Progesterone Receptor, Ki-67, Human Epidermal Growth Factor Receptor 2, basal cytokeratins 5/6, and Epidermal Growth Factor Receptor. Multivariate survival analyses were performed using the Cox proportional hazards model.
Results
The overall survival after mastectomy was 11 months. Within 1 year post mastectomy, 41.5% of dogs (145/350) died from their mammary carcinoma. By multivariate analysis, the significant prognostic factors for overall survival included a pathologic tumor size larger than 20 mm [HR 1.47 (95% confidence interval 1.15–1.89)], a positive nodal stage [pN+, HR 1.89 (1.43–2.48)], a histological grade III [HR 1.32 (1.02–1.69)], ERα negativity [HR 1.39 (1.01–1.89)], a high Ki-67 proliferation index [HR 1.32 (1.04–1.67)], and EGFR absence [HR 1.33 (1.04–1.69)].
Conclusion
The short natural history of spontaneous canine invasive mammary carcinomas and high rate of cancer-related death allow for rapid termination of preclinical investigations. The prognostic factors of invasive mammary carcinomas are remarkably similar in dogs and humans, highlighting the similarities in cancer biology between both species.</description><subject>Animal models</subject><subject>Animals</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - pathology</subject><subject>Breast Neoplasms - surgery</subject><subject>Cancer</subject><subject>Cancer research</subject><subject>Clinical trials</subject><subject>Disease Models, Animal</subject><subject>Dogs</subject><subject>Epidermal growth factor</subject><subject>Epidermal growth factor receptors</subject><subject>Epidermal growth factors</subject><subject>Estrogens</subject><subject>Female</subject><subject>Humans</subject><subject>Invasiveness</subject><subject>Life Sciences</subject><subject>Mammary gland</subject><subject>Mammary Neoplasms, Animal - genetics</subject><subject>Mammary Neoplasms, Animal - pathology</subject><subject>Mammary Neoplasms, Animal - surgery</subject><subject>Mastectomy</subject><subject>Medical prognosis</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Multivariate Analysis</subject><subject>Neoplasm Invasiveness - genetics</subject><subject>Neoplasm Invasiveness - pathology</subject><subject>Oncology</subject><subject>Preclinical Study</subject><subject>Progesterone</subject><subject>Prognosis</subject><subject>Receptor, ErbB-2 - genetics</subject><subject>Receptors, Estrogen - genetics</subject><subject>Receptors, Progesterone - genetics</subject><subject>Survival</subject><issn>0167-6806</issn><issn>1573-7217</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1klGL1DAUhYso7rr6A3yRgCA-2PEmbZLJPgjDoK4woA_6HDJpOs3SJmPSDvjvvWXWdWbRthBIvnNy7-ktipcUFhRAvs8UeK1KoLKseb0s2aPiknJZlZJR-bi4BCpkKZYgLopnOd8CgJKgnhYXTMFSsIpeFnltgg-O-HAw2R8cGcwwmPSLWJOsD3EwmeA3xMb1mcSWdNNgAtkmZ_KIULAuLcg3k0ZCr0kw45RMTzqfx4gmJjRkn-IuxDx6S1pjcTs_L560ps_uxd16Vfz49PH7-qbcfP38Zb3alFZIOpZMibZlqqKc12IL9RKggmoLQmypakA41lRUthaEsrzhTCAGynAlmspin9VV8eHou5-2g2usCyMWp_fJzx3qaLw-Pwm-07t40HwJslY1Grw7GnQPZDerjfYhuzRozJgprO1AEX97d1-KPyeXRz34bF3fm-DilDVVfMkrVYkZff0AvY1TCpgGUvjQuf6_1M70Di9sI5ZpZ1O94kxShr9TILX4B4Vv4wZvY3Ctx_0zwZsTQedMP3Y59tPoY8jnID2CNsWck2vvQ6Cg5wnUxwnEEKSeJ1Az1Lw6Df1e8WfkEGBHIONR2Ll00vp_XX8DZv7jMg</recordid><startdate>20180201</startdate><enddate>20180201</enddate><creator>Nguyen, Frédérique</creator><creator>Peña, Laura</creator><creator>Ibisch, Catherine</creator><creator>Loussouarn, Delphine</creator><creator>Gama, Adelina</creator><creator>Rieder, Natascha</creator><creator>Belousov, Anton</creator><creator>Campone, Mario</creator><creator>Abadie, Jérôme</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><general>Springer Verlag</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7203-2982</orcidid><orcidid>https://orcid.org/0000-0002-3538-0782</orcidid><orcidid>https://orcid.org/0000-0002-5196-5908</orcidid><orcidid>https://orcid.org/0000-0002-7750-0519</orcidid></search><sort><creationdate>20180201</creationdate><title>Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors</title><author>Nguyen, Frédérique ; Peña, Laura ; Ibisch, Catherine ; Loussouarn, Delphine ; Gama, Adelina ; Rieder, Natascha ; Belousov, Anton ; Campone, Mario ; Abadie, Jérôme</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c671t-296ff29315546b04800303b066b19d06e2d317fc069c5d52654609a596d3c7093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animal models</topic><topic>Animals</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - pathology</topic><topic>Breast Neoplasms - surgery</topic><topic>Cancer</topic><topic>Cancer research</topic><topic>Clinical trials</topic><topic>Disease Models, Animal</topic><topic>Dogs</topic><topic>Epidermal growth factor</topic><topic>Epidermal growth factor receptors</topic><topic>Epidermal growth factors</topic><topic>Estrogens</topic><topic>Female</topic><topic>Humans</topic><topic>Invasiveness</topic><topic>Life Sciences</topic><topic>Mammary gland</topic><topic>Mammary Neoplasms, Animal - genetics</topic><topic>Mammary Neoplasms, Animal - pathology</topic><topic>Mammary Neoplasms, Animal - surgery</topic><topic>Mastectomy</topic><topic>Medical prognosis</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Multivariate Analysis</topic><topic>Neoplasm Invasiveness - genetics</topic><topic>Neoplasm Invasiveness - pathology</topic><topic>Oncology</topic><topic>Preclinical Study</topic><topic>Progesterone</topic><topic>Prognosis</topic><topic>Receptor, ErbB-2 - genetics</topic><topic>Receptors, Estrogen - genetics</topic><topic>Receptors, Progesterone - genetics</topic><topic>Survival</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nguyen, Frédérique</creatorcontrib><creatorcontrib>Peña, Laura</creatorcontrib><creatorcontrib>Ibisch, Catherine</creatorcontrib><creatorcontrib>Loussouarn, Delphine</creatorcontrib><creatorcontrib>Gama, Adelina</creatorcontrib><creatorcontrib>Rieder, Natascha</creatorcontrib><creatorcontrib>Belousov, Anton</creatorcontrib><creatorcontrib>Campone, Mario</creatorcontrib><creatorcontrib>Abadie, Jérôme</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Breast cancer research and treatment</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nguyen, Frédérique</au><au>Peña, Laura</au><au>Ibisch, Catherine</au><au>Loussouarn, Delphine</au><au>Gama, Adelina</au><au>Rieder, Natascha</au><au>Belousov, Anton</au><au>Campone, Mario</au><au>Abadie, Jérôme</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors</atitle><jtitle>Breast cancer research and treatment</jtitle><stitle>Breast Cancer Res Treat</stitle><addtitle>Breast Cancer Res Treat</addtitle><date>2018-02-01</date><risdate>2018</risdate><volume>167</volume><issue>3</issue><spage>635</spage><epage>648</epage><pages>635-648</pages><issn>0167-6806</issn><eissn>1573-7217</eissn><abstract>Purpose
Dogs have been proposed as spontaneous animal models of human breast cancer, based on clinicopathologic similarities between canine and human mammary carcinomas. We hypothesized that a better knowledge of the natural history and prognostic factors of canine invasive mammary carcinomas would favor the design of preclinical trials using dogs as models of breast cancer.
Methods
The 2-year outcome of 350 female dogs with spontaneous invasive mammary carcinoma was studied. The investigated prognostic factors included age at diagnosis, pathologic tumor size, pathologic nodal stage, lymphovascular invasion, histological grade, and expression of Estrogen Receptor alpha (ERα), Progesterone Receptor, Ki-67, Human Epidermal Growth Factor Receptor 2, basal cytokeratins 5/6, and Epidermal Growth Factor Receptor. Multivariate survival analyses were performed using the Cox proportional hazards model.
Results
The overall survival after mastectomy was 11 months. Within 1 year post mastectomy, 41.5% of dogs (145/350) died from their mammary carcinoma. By multivariate analysis, the significant prognostic factors for overall survival included a pathologic tumor size larger than 20 mm [HR 1.47 (95% confidence interval 1.15–1.89)], a positive nodal stage [pN+, HR 1.89 (1.43–2.48)], a histological grade III [HR 1.32 (1.02–1.69)], ERα negativity [HR 1.39 (1.01–1.89)], a high Ki-67 proliferation index [HR 1.32 (1.04–1.67)], and EGFR absence [HR 1.33 (1.04–1.69)].
Conclusion
The short natural history of spontaneous canine invasive mammary carcinomas and high rate of cancer-related death allow for rapid termination of preclinical investigations. The prognostic factors of invasive mammary carcinomas are remarkably similar in dogs and humans, highlighting the similarities in cancer biology between both species.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>29086231</pmid><doi>10.1007/s10549-017-4548-2</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0001-7203-2982</orcidid><orcidid>https://orcid.org/0000-0002-3538-0782</orcidid><orcidid>https://orcid.org/0000-0002-5196-5908</orcidid><orcidid>https://orcid.org/0000-0002-7750-0519</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0167-6806 |
ispartof | Breast cancer research and treatment, 2018-02, Vol.167 (3), p.635-648 |
issn | 0167-6806 1573-7217 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5807494 |
source | MEDLINE; SpringerNature Journals |
subjects | Animal models Animals Breast cancer Breast Neoplasms - pathology Breast Neoplasms - surgery Cancer Cancer research Clinical trials Disease Models, Animal Dogs Epidermal growth factor Epidermal growth factor receptors Epidermal growth factors Estrogens Female Humans Invasiveness Life Sciences Mammary gland Mammary Neoplasms, Animal - genetics Mammary Neoplasms, Animal - pathology Mammary Neoplasms, Animal - surgery Mastectomy Medical prognosis Medicine Medicine & Public Health Multivariate Analysis Neoplasm Invasiveness - genetics Neoplasm Invasiveness - pathology Oncology Preclinical Study Progesterone Prognosis Receptor, ErbB-2 - genetics Receptors, Estrogen - genetics Receptors, Progesterone - genetics Survival |
title | Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T03%3A17%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Canine%20invasive%20mammary%20carcinomas%20as%20models%20of%20human%20breast%20cancer.%20Part%201:%20natural%20history%20and%20prognostic%20factors&rft.jtitle=Breast%20cancer%20research%20and%20treatment&rft.au=Nguyen,%20Fr%C3%A9d%C3%A9rique&rft.date=2018-02-01&rft.volume=167&rft.issue=3&rft.spage=635&rft.epage=648&rft.pages=635-648&rft.issn=0167-6806&rft.eissn=1573-7217&rft_id=info:doi/10.1007/s10549-017-4548-2&rft_dat=%3Cgale_pubme%3EA527129706%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1999917093&rft_id=info:pmid/29086231&rft_galeid=A527129706&rfr_iscdi=true |